Utilization Review (UR) for Sarcoma Treatment

UR's Role in Sarcoma treatment

Individuals battling sarcoma will undergo countless tests, procedures and treatments over the course of months or years. The goal of Utilization Review is for patients to receive the best care possible. Insurers use an evidence-based approach during Utilization Review to make sure patients do not receive duplicate or un-proven procedures.   Utilization Review During Sarcoma […]

New Findings in Sarcoma

Sarcoma

Sarcoma is a rare type of cancer, making up about 1 percent of all adult cancers and about 15 percent of pediatric cancers, according to the Liddy Shriver Sarcoma Initiative. Despite the high rate for childhood and adolescent cancers, the total number of pediatric sarcoma cases is far lower than adult cases because overall there […]

Sarcoma Awareness – Overview of Sarcoma

Sarcoma

July is Sarcoma Awareness Month, making it an appropriate time to spread information about this disease and medical advancements surrounding its treatment. The Sarcoma Alliance estimates there are about 14,000 new diagnoses of sarcoma every year. While it is a relatively rare cancer, researchers and physicians continue to try and better understand why it develops […]

Biosimilar Drugs – An Infographic

AMR Biosimilar Infographic

AMR’s latest infographic looks at the both the benefits and concerns of Biosimilar drugs.

The Role of EHRs in Patient Care

EHR

When people visit emergency rooms or even their family physicians, they are more likely to see the doctor use a computer or tablet in the office than pull out a paper file. This is because the health care industry has heavily shifted toward using electronic health records (EHR). These records encapsulate all patient data from […]

IMRs Ensure Patients Receive Objective Decisions Regarding Genetic Testing

genetic-testing-image

Genetic testing is prevalent in modern medicine. It gives physicians definite information about the patient, often supporting a diagnosis or influencing a treatment plan. Common types of genetic tests are prenatal testing and newborn screening for specific diseases or syndromes, predictive and carrier testing such as for the “breast cancer gene” BRCA, or diagnostic testing. […]

Opioid Study Shows the Danger is in the Dosage

opioids

In the U.S., prescriptions for and sales of opioid painkillers have nearly quadrupled since 1999, according to the Centers for Disease Control and Prevention. Researchers from the University of Michigan Medical School and the Department of Veterans Affairs’ Ann Arbor Healthcare System published a new study in the online journal Medical Care exposing a major […]

FDA’s Drug Approval Process – How it Fits into the US Health Delivery System

fda-approved-stamp copy

The U.S. Food and Drug Administration has a rigorous drug approval method, but recent years have shown that even this thorough process undergoes certain trends. Each year more new drug applications (NDA) are submitted and approved, including specialty drugs. The annual increase in the approval rates of novel and specialty drugs may signal a general […]

PBMs: Past, Present and Future

PBM Drug Reviews

Not every aspect of the shifting health care market is clear, but one thing is for certain: The importance of pharmacy benefit management companies (PBMs) is increasing. Drug prices are rising, and PBMs continue to act as intermediaries between insurance companies, pharmacies and manufacturers to reduce prices for insurers and patients whenever possible. PBMs have […]

URAC accreditation: What does it mean?

URAC image

In the late 1980s, there were no existing uniform standards for utilization review services, raising concern within the industry and highlighting a need for oversight. The Utilization Review Accreditation Commission was incorporated in 1990 to offer health organizations an opportunity to have trained reviewers examine their operations and publicly ensure they are delivering care in […]

« Older posts